Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial.
Jonker DJ, Tang PA, Kennecke H, Welch SA, Cripps MC, Asmis T, Chalchal H, Tomiak A, Lim H, Ko YJ, Chen EX, Alcindor T, Goffin JR, Korpanty GJ, Feilotter H, Tsao MS, Theis A, Tu D, Seymour L. Jonker DJ, et al. Among authors: cripps mc. Clin Colorectal Cancer. 2018 Sep;17(3):231-239.e7. doi: 10.1016/j.clcc.2018.03.001. Epub 2018 Mar 8. Clin Colorectal Cancer. 2018. PMID: 29653857 Clinical Trial.
Duration of intravenous antibiotics for patients with neutropenic fever.
Tomiak AT, Yau JC, Huan SD, Cripps MC, Goel R, Perrault DJ, Bourcier JD, Prosser IA, Soltys KM, Evans WK, et al. Tomiak AT, et al. Among authors: cripps mc. Ann Oncol. 1994 May;5(5):441-5. doi: 10.1093/oxfordjournals.annonc.a058877. Ann Oncol. 1994. PMID: 8075051 Free article.
Effects of PALA on the pharmacokinetics of 5-fluorouracil.
Nassim MA, Rouini MR, Cripps MC, Shirazi FH, Veerasinghan S, Molepo JM, Obrocea M, Redmond D, Bates S, Fry D, Stewart DJ, Goel R. Nassim MA, et al. Among authors: cripps mc. Oncol Rep. 1998 Jan-Feb;5(1):217-21. Oncol Rep. 1998. PMID: 9458325 Clinical Trial.
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD, Von Hoff DD. Burris HA 3rd, et al. Among authors: cripps mc. J Clin Oncol. 1997 Jun;15(6):2403-13. doi: 10.1200/JCO.1997.15.6.2403. J Clin Oncol. 1997. PMID: 9196156 Corrected and republished. Clinical Trial.
18 results